Current status of thrombolytics—the need for better, especially safer, agents
To access this article, please choose from the options below
PII: S0049-3848(08)00237-5
doi:10.1016/j.thromres.2008.06.008
© 2008 Elsevier Ltd. All rights reserved.
PII: S0049-3848(08)00237-5
doi:10.1016/j.thromres.2008.06.008
© 2008 Elsevier Ltd. All rights reserved.